Bio-Rad Laboratories BIO Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's long-term debt?
- Bio-Rad Laboratories (BIO) reported long-term debt of $802.9M in Q1 2026.
- How has Bio-Rad Laboratories's long-term debt changed year-over-year?
- Bio-Rad Laboratories's long-term debt decreased by 33.1% year-over-year, from $1.2B to $802.9M.
- What is the long-term trend for Bio-Rad Laboratories's long-term debt?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's long-term debt has grown at a 150.2% compound annual growth rate (CAGR), from $12.26M to $1.2B.
- What does long-term debt mean?
- Debt that is not due to be paid back for at least one year.
- How do you interpret long-term debt?
- High levels of long-term debt increase financial leverage and interest expense, which can impact profitability, though it may also indicate growth-oriented capital investment.
- How does long-term debt compare across companies?
- Standard metric for assessing the capital structure and solvency of large-cap companies.